Characterization of patients with advanced non-small-cell lung cancer (NSCLC) harboring KRASG12C mutation and their associated direct healthcare costs in Spanish routine clinical practice (SILK study)

被引：0
|
作者：
Aransay, N. Reguart [1 ]
Sanchez, J. [1 ]
Vidal, O. J. Juan [2 ]
Domingo, M. Aguilo [3 ]
Arriola, E. [4 ]
Lopez, C. [2 ]
Botella, X. [3 ]
Cots, F. [4 ]
Montironi, C. [5 ]
Palanca, S.
Borras, E. [3 ]
Pinto, L. Masfarre [4 ]
Planellas, L. [6 ]
Vila, A. Lloansi [6 ]
机构：
[1] Hosp Clin Barcelona, Dept Med Oncol, Barcelona, Spain
[2] Hosp Univ Politecn La Fe, Dept Med Oncol, Valencia, Spain
[3] Hosp Terrassa Consorci Sanitari Terrassa, Med Oncol, Terrassa, Spain
[4] Hosp Mar Parc Salut Mar, Dept Med Oncol, Barcelona, Spain
[5] Hosp Clin Barcelona, Pathol, Barcelona, Spain
[6] Amgen Spain, Barcelona, Spain
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.09.2442
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1410P
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Direct costs associated with the disease management of patients with unresectable advanced non-small-cell lung cancer in The Netherlands
    Pompen, Marjolein
    Gok, Murat
    Novak, Annoesjka
    van Wuijtswinkel, Rob
    Biesma, Bonne
    Schramel, Franz
    Stigt, Jos
    Smit, Hans
    Postmus, Pieter
    LUNG CANCER, 2009, 64 (01) : 110 - 116
  • [22] Efficacy and toxicity of drugs targeting KRASG12C mutation in non-small cell lung cancer: a meta-analysis
    Luo, Wei
    Zhu, Jing
    Zhang, Wenxue
    Yu, Airu
    Zhou, Wei
    Xu, Ke
    EXPERT REVIEW OF ANTICANCER THERAPY, 2023, 23 (12) : 1295 - 1303
  • [23] Molecular and clinical characteristics of patients with non-small-cell lung cancer (NSCLC) harboring KRAS G12V mutations
    John, Felix
    Ruge, Lea
    Scharpenseel, Heather
    Siemanowski, Janna
    Fassunke, Jana
    Riedel, Richard
    Michels, Sebastian Yves Friedrich
    Fischer, Rieke Nila
    Rasokat, Anna
    Schulte, Wolfgang
    Franke, Karl-Josef
    Graeven, Ullrich
    Kappes, Jutta
    Kron, Anna
    Siebolts, Udo
    Merkelbach-Bruse, Sabine
    Buettner, Reinhard
    Wolf, Juergen
    Scheffler, Matthias
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [24] KRASG12C mutation-induced TOPK overexpression contributes to tumour progression in non-small cell lung cancer
    Cai, Chang
    Yao, Shuo
    Zou, Yanmei
    Lu, Hui
    Chen, Xiuqiong
    Wang, Yali
    Zheng, Kun
    Zhu, Feng
    Wang, Yihua
    Xiong, Hua
    Zhu, Junfei
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2023, 27 (12) : 1637 - 1652
  • [25] ANNUAL COSTS OF BEST SUPPORTIVE CARE FOR PATIENTS WITH ADVANCED NON-SMALL-CELL LUNG CANCER (NSCLC) IN GERMANY
    Mathes, J.
    Kern, B.
    Kotowa, W.
    VALUE IN HEALTH, 2017, 20 (09) : A430 - A430
  • [26] Clinical characteristics associated with non-small-cell lung cancer harboring ALK rearrangements in Chinese patients
    Tian, Guangming
    Zhao, Xinliang
    Nie, Jun
    Dai, Ling
    Hu, Weiheng
    Zhang, Jie
    Chen, Xiaoling
    Han, Jindi
    Ma, Xiangjuan
    Wu, Di
    Han, Sen
    Long, Jieran
    Wang, Yang
    Fang, Jian
    FUTURE ONCOLOGY, 2016, 12 (10) : 1243 - 1249
  • [27] Taking ACTION to establish direct costs and outcomes of treating advanced non-small cell lung cancer in routine clinical practice
    Cullen, M
    Szczepura, A
    Kielhorn, A
    LUNG CANCER, 2004, 43 (01) : 113 - 115
  • [28] CLINICAL ACTIVITY OF CRIZOTINIB IN ADVANCED NON-SMALL-CELL LUNG CANCER (NSCLC) HARBORING ROS1 GENE REARRANGEMENT
    Bang, Y. -J.
    Ou, S.
    Camidge, D. R.
    Clark, J. W.
    Wilner, K.
    Tye, L.
    Stephenson, P.
    Varella-Garcia, M.
    Iafrate, A. J.
    Shaw, A. T.
    ANNALS OF ONCOLOGY, 2012, 23 : 33 - 33
  • [29] PREDICTIVE FACTORS ASSOCIATED WITH GEFITINIB RESPONSE IN PATIENTS WITH ADVANCED NON-SMALL-CELL LUNG CANCER (NSCLC)
    Xu, F.
    Zhou, T.
    Duan, J.
    ANNALS OF ONCOLOGY, 2012, 23 : 47 - 47
  • [30] Predictive factors associated with gefitinib response in patients with advanced non-small-cell lung cancer (NSCLC)
    Chen, Lian
    Chen, Rui
    Zhu, Zhe
    Zhang, Yichen
    Wen, Zhengwei
    Li, Yun
    Li, Xiaoming
    Luo, Yuwen
    Ma, Liyu
    Lin, Shuguang
    Chen, Xin
    CHINESE JOURNAL OF CANCER RESEARCH, 2014, 26 (04) : 466 - 470
12345